Immune Reconstitution in HIV+ Subjects on Lopinavir/Ritonavir-Based HAART According to the Severity of Pre-Therapy CD4+

E-ISSN： 1873-4251|10|7|597-605

ISSN： 1570-162X

Source： Current HIV Research, Vol.10, Iss.7, 2012-09, pp. : 597-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Opportunistic Infections Prior to HAART Initiation Does Not Affect Immune Reconstitution in HIV-Infected Patients

Current HIV Research, Vol. 10, Iss. 7, 2012-09 ,pp. : 592-596

Bentham Science Publishers

Access to resources Recommend Favorite

HIV DNA and Immune Alteration During Successful HAART

Current HIV Research, Vol. 11, Iss. 4, 2013-06 ,pp. : 255-262

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of HIV-1 and CD4+ T Cell Dynamic Parameters in Patients Treated with Genotypic Resistance Testing-Guided HAART

Current HIV Research, Vol. 6, Iss. 4, 2008-07 ,pp. : 363-369

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Term CD4 Cell Count Recovery among Thai Naive HIV-Infected Patients Initiating HAART at Low CD4 Cell Count

Current HIV Research, Vol. 7, Iss. 3, 2009-05 ,pp. : 340-345

Bentham Science Publishers

Access to resources Recommend Favorite

Fat Tissue Distribution Changes in HIV-Infected Patients Treated with Lopinavir/Ritonavir. Results of the MONARK Trial

Current HIV Research, Vol. 9, Iss. 1, 2011-01 ,pp. : 31-39

Bentham Science Publishers

Access to resources Recommend Favorite